Home / Companies / News / Serum to have 200 mn doses of AstraZeneca coronavirus vaccine ready by Jan

Serum to have 200 mn doses of AstraZeneca coronavirus vaccine ready by Jan

Pune company recruits over 1,600 participants in India for phase 3 trials of Covishield.

Serum institute, coronavirus, vaccine, pharma, drugs

Premium

ICMR would be funding the clinical trials in India. It is also working closely with SII for the Covishield vaccine trials across 15 centers in India

Sohini Das Mumbai

5 min read Last Updated : Nov 13 2020 | 12:30 AM IST

Pune's Serum Institute of India (SII) will have 200 million doses of the AstraZeneca-Oxford University vaccine for the coronavirus ready by January, ramping up its capacity to make 100 million doses of the inoculation monthly..

Sources said the company has recruited over 1,600 participants in India for phase 3 trials of Covishield (the AstraZeneca vaccine candidate).

All participants have received the first shot of the vaccine and by the end of November, the second shot would be completed. Data analysis would begin after the second shot, sources said.

"SII has started stock-piling the vaccine and now has roughly 40

Topics : Coronavirus Serum Institute Coronavirus Vaccine Coronavirus Tests

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in